SciClone Raises Standards, and Eyebrows, With FCPA Deal

By Jaclyn Jaeger2011-11-29T00:00:00

lock icon THIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.

Become a Member

News and analysis for the well-informed compliance or audit exec. Select an option and click continue.

Annual Membership $499 Value offer

Full price one year membership with auto-renewal.

Membership $599

One-year only, no auto-renewal.

Access CW Newsletters and CPE webcasts. REGISTER FOR LIMITED FREE ACCESS

Already a Compliance Week member?

Blog
SciClone Could Pay SEC $12.8 Million in FCPA Case

2015-08-14T11:00:00Z By Jaclyn Jaeger

SciClone Pharmaceuticals has disclosed in a quarterly report that it’s discussing a tentative $12.8 million settlement with the Securities and Exchange Commission to resolve an investigation of potential violations of the Foreign Corrupt Practices Act with respect to its China operations. Details inside.
Article
Lost in Translation: How Language Is Complicating Global Compliance

2012-08-14T00:00:00Z By Joe Mont
Article
The High Cost of FCPA Investigations

2012-04-17T00:00:00Z By Jaclyn Jaeger